Skip to main content
Mallory
MediumVulnerability

CVE-2026-4913: Account Disablement Bypass in Ivanti Neurons for ITSM

Published Apr 14, 2026 · Updated 23 days ago
Trending this weekNot trendingOutside this week’s top 100
Mention activity · 30 daysNo mention activity in the last 30 days.
CVSS5.7Medium · v3.1
EPSS0.60%49th percentile
CISA KEVNoNot listed
In the wildNoneNo exploitation reported
IdentifiersCVE-2026-4913CWE-424 · Improper Protection of Alternate…

CVE-2026-4913 is an improper protection of an alternate path vulnerability in Ivanti Neurons for ITSM versions before 2025.4. A remote authenticated attacker can retain access through an alternate path after an administrator disables the attacker's account, bypassing account-disablement controls. The vulnerability affects on-premises and cloud deployments and has a CVSS score of 5.7 (Medium). The specific vulnerable function and alternate-path mechanism have not been disclosed.

Do you run this?See affected versions in your environment and whether adversaries are exploiting this vulnerability against assets like yours.
Check your exposure
Analyst brief

Impact, mitigation & remediation

What it means and what to do now: patch path, interim mitigations, and the assume-compromise checklist.

Impact

What an attacker gets, and what they’ve been doing with it.

Successful exploitation defeats account-disablement controls, allowing continued unauthorized access and potentially exposing confidential information accessible to the affected account. Privilege escalation or access beyond the account's existing permissions is not established.

Mitigation

If you can’t patch tonight, do this now.

No temporary workaround has been specified. Account disablement alone cannot be relied upon to terminate access on vulnerable installations; apply the fixed release.

Remediation

Patch, then assume compromise.

Upgrade affected on-premises Ivanti Neurons for ITSM installations to version 2025.4 or a later fixed release. Version 2025.4 is available through the Ivanti License System. Ivanti applied the fixes to all cloud environments on December 12, 2025; cloud customers require no action for this vulnerability.

Public exploits

Exploits

No public exploits tracked yet. Mallory keeps watching.

View more in app →
No public exploit code observed for this vulnerability. Mallory keeps watching.
FAQ

Frequently asked questions

Is CVE-2026-4913 exploited in the wild?
As of Oct 25, 2026, Mallory has no reports of CVE-2026-4913 being exploited in the wild. It is not listed in CISA KEV.
Is there a public exploit for CVE-2026-4913?
As of Oct 25, 2026, Mallory has found no public exploit for CVE-2026-4913.
Is there a patch for CVE-2026-4913?
Upgrade affected on-premises Ivanti Neurons for ITSM installations to version 2025.4 or a later fixed release. Version 2025.4 is available through the Ivanti License System.
How severe is CVE-2026-4913?
CVE-2026-4913 has a CVSS v3.1 score of 5.7 (Medium) and an EPSS score of 0.60% (49th percentile) as of Oct 25, 2026.
Mallory platform

The version that knows your environment.

This page is what’s public. Mallory adds the parts that aren’t: which of your assets are affected, which adversaries are exploiting it right now, and which detections to deploy tonight.
Exposure mappingQuery your assets running an affected version, and investigate the blast radius.
Threat actor evidenceEvery report linking this CVE to a named adversary.
Associated malwareMalware families linked to this CVE, with evidence and IOCs.
Detection signaturesYARA, Sigma, Snort, and vendor rules, auto-deployed to your SIEM.
Vendor-by-vendor mappingCross-references every affected SKU, including bundled OEM variants.
Social activity6Community discussion across Reddit, Mastodon, and other social sources.